Bungled Key/Len RCC Launch

[anonymous]

Selling off the PI and shitty RTEs. Heads should but won’t roll because Eisai embraces mediocrity. Let Merck do the heavy lifting

 

[anonymous]

Don't you know, we are too busy trying to figure out role playing to make things happen. I use to have a sales job, now it's a see what internal people can do to keep us out of the field job. Too primary are for me.

 

[anonymous]

Launch team still on the runway in their fighter jets. Comical

 

[anonymous]

Eisai is in oncology?

 

[anonymous]

Who did the dude?

 

[anonymous]

Who did the dude?

Alex.

 

[anonymous]

This is a primary care company trying to act like its an oncology company.

 

[anonymous]

This is a primary care company trying to act like its an oncology company.

That’s been true for years.

 

[anonymous]

I hear Merck is going to take over any sales of combinations with Keytruda in the spring. Eisai will reorganize to a specialty sales force for everything else, HCC, DTC, I guess. Any truth to this?

 

[anonymous]

End of fiscal year changes will be made.

 

[anonymous]

End of fiscal year changes will be made.

A lot of dead weight to cut!

 

[anonymous]

End of fiscal year changes will be made.

I’m hearing just in Onc.

 

[anonymous]

I’m hearing just in Onc.

I hear across the board

 

[anonymous]

What kind of changes. we are waiting fir more indications so maybe more expansion for lung/melanoma

 

[anonymous]

What kind of changes. we are waiting fir more indications so maybe more expansion for lung/melanoma

Merck taking over

 

[anonymous]

What kind of changes. we are waiting fir more indications so maybe more expansion for lung/melanoma

A lot of opportunity coming